Francesca Vitale

Francesca Vitale

Auto-generated profile, based on publicly available information

Francesca Vitale

Unit of Pediatric Intensive Care, A. Gemelli Hospital, Sacred Heart Catholic University, Rome, Italy

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
PAPaola Aceto
Paola Aceto
VPValter Perilli
Valter Perilli
CMCristina Modesti
Cristina Modesti
PCPierpaolo Ciocchetti
Pierpaolo Ciocchetti
FVFrancesca Vitale
Francesca Vitale
LSLiliana Sollazzi
Liliana Sollazzi

1 January 2009 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
LSLiliana Sollazzi
Liliana Sollazzi
CMCristina Modesti
Cristina Modesti
FVFrancesca Vitale
Francesca Vitale
TSTeresa Sacco
Teresa Sacco
PCPierpaolo Ciocchetti
Pierpaolo Ciocchetti
VPValter Perilli
Valter Perilli

1 February 2017 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
PDF file
Angela AmigoniAngela Amigoni
Angela Amigoni
MMMaria Cristina Mondardini
Maria Cristina Mondardini
IVIlaria Vittadello
Ilaria Vittadello
FZFederico Zaglia
Federico Zaglia
EREmanuele Rossetti
Emanuele Rossetti
LFLinda S. Franck
Linda S. Franck
Objectives: Withdrawal syndrome is an adverse reaction of analgesic and sedative therapy, with a reported occurrence rate between 17% and 57% in critically ill children. Although some factors related to the development of withdrawal syndrome have been identified, there is weak evidence for the effectiveness of preventive and therapeutic strategies. The main aim of this study was to evaluate the frequency of withdrawal syndrome in Italian PICUs, using a validated instrument. We also analyzed differences in patient characteristics, analgesic and sedative treatment, and patients’ outcome between patients with and without withdrawal syndrome. Design: Observational multicenter prospective study. Setting: Eight Italian PICUs belonging to the national PICU network Italian PICU network. Patients: One hundred thirteen patients, less than 18 years old, mechanically ventilated and treated with analgesic and sedative therapy for five or more days. They were admitted in PICU from November 2012 to May 2014. Interventions: Symptoms of withdrawal syndrome were monitored with Withdrawal Assessment Tool-1 scale. Measurements and Main Results: The occurrence rate of withdrawal syndrome was 64.6%. The following variables were significantly different between the patients who developed withdrawal syndrome and those who did not: type, duration, and cumulative dose of analgesic therapy; duration and cumulative dose of sedative therapy; clinical team judgment about analgesia and sedation’s difficulty; and duration of analgesic weaning, mechanical ventilation, and PICU stay. Multivariate logistic regression analysis revealed that patients receiving morphine as their primary analgesic were 83% less likely to develop withdrawal syndrome than those receiving fentanyl or remifentanil. Conclusions: Withdrawal syndrome was frequent in PICU patients, and patients with withdrawal syndrome had prolonged hospital treatment. We suggest adopting the lowest effective dose of analgesic and sedative drugs and frequent reevaluation of the need for continued use. Further studies are necessary to define common preventive and therapeutic strategies.

1 February 2019 in Minerva Anestesiologica
Verified
Journal Article
Closed access
FSFrancesca Sperotto
Francesca Sperotto
OGon behalf of the Pediatric Neurological Protection and Drugs (PeNPAD) Study Group
on behalf of the Pediatric Neurological Protection and Drugs (PeNPAD) Study Group
MMMaria C. Mondardini
Maria C. Mondardini
FVFrancesca Vitale
Francesca Vitale
MDMarco Daverio
Marco Daverio
Angela AmigoniAngela Amigoni
Angela Amigoni
Dexmedetomidine (DEX) is an alpha-2-adrenergic agonist, recently approved by Italian-Medicines-Agency for difficult sedation in pediatrics, but few data exist regarding prolonged infusions in critically-ill children, especially in younger ages. Aim of our study was to evaluate DEX use and safety for prolonged sedation in Pediatric Intensive Care Units (PICUs). Patients receiving DEX for ≥24 hours were retrospectively evaluated to analyze DEX indications, dosages, use of analgesics or sedatives, adverse events (AEs), withdrawal syndrome or delirium. Forty-seven patients (median 0.7years) from nine PICUs were enrolled. Main indications were adjuvant for drugs sparing (59.6%) and for analgosedation weaning (36.2%). Median infusion duration was 82.0 hours (IQR 62.2-126.0), with dosages between 0.4 (IQR 0.2-0.5) and 0.8 mcg/kg/h (IQR 0.6-1.2). Fifty-nine-percent of patients received other sedatives, 83% other analgesics. Twenty-one-percent presented withdrawal syndrome, 4.2% delirium, none of them DEX-related. Forty-six-percent experienced a potentially-DEX-related AE. AEs were all hemodynamic, 14.9% requiring intervention but none DEX interruption. The median minimum and maximum dosages were significantly higher in patients with AEs (0.5 vs. 0.3,P=0.001; 1.0 vs. 0.7,P<0.001), without correlations with the infusion duration. AEs rate was higher in patients receiving benzodiazepines (P=0.020) or more than one analgesic (P=0.003) and in those presenting withdrawal syndrome (P<0.001). DEX was confirmed as useful and relatively safe drug for prolonged sedation in critically-ill children, particularly in younger ages. Main AEs were cardiovascular, reversible, related with higher doses, with the concomitant use of benzodiazepines or multiple sedation drugs and with the presence of withdrawal syndrome.

13 June 2012 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
DPDomenico Pietrini
Domenico Pietrini
MPMariano Pennisi
Mariano Pennisi
FVFrancesca Vitale
Francesca Vitale
SPSilvia Maria Pulitanò
Silvia Maria Pulitanò
GCGiorgio Conti
Giorgio Conti
DLDaniele De Luca
Daniele De Luca

1 July 2016
Verified
Journal Article
Closed access
VPValter Perilli
Valter Perilli
PAPaola Aceto
Paola Aceto
TST Sacco
T Sacco
CMC Modesti
C Modesti
PCP Ciocchetti
P Ciocchetti
LSL Sollazzi
L Sollazzi